Table 3.
AlPcS4Cl-PDT dose–response on A549 lung cancer cells. An [IC50]* was achieved using 20 µM AlPcS4Cl and a fluence of 10 J cm−2 [23].
| dose AlPcS4Cl (µM): fluence (J cm−2) | cytotoxicity (%) | proliferation (%) | viability (%) |
|---|---|---|---|
| 0 : 5 | 0.904532 | 100 | 90.33333 |
| 5 : 5 | 11.98658 | 70.83903 | 89 |
| 10 : 5 | 20.0843 | 33.1369 | 82 |
| 20 : 5 | 24.61926 | 14.15428 | 69 |
| 0 : 10 | 0.922992 | 100 | 90.33333 |
| 5 : 10 | 5.48257 | 84.23562 | 81.66667 |
| 10 : 10 | 23.35169 | 44.45995 | 63.66667 |
| 20 : 10 | *24.94538 | *30.52207 | *42 |
| 0 : 15 | 5.07769 | 100 | 91 |
| 5 : 15 | 12.40134 | 105.5512 | 79.66667 |
| 10 : 15 | 37.60235 | 79.72145 | 66.66667 |
| 20 : 15 | 39.01121 | 60.12904 | 33 |